Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment

Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorBruce Robinson, MD

About this trial

The investigators seek to evaluate the effectiveness of fractional laser therapy and tirbanibulin ointment to treat squamous and basal cell carcinomas. This will be executed by using both thulium and erbium lasers on previously biopsy-confirmed SCCs and BCCs and applying bulk heating methods. Then, depending on the level of invasiveness, subjects may be instructed to apply the ointment over the course of five nights immediately following the treatment. The intention of this study is to minimize the need for invasive surgical procedures so as to optimize the cosmetic appearance, and provide a treatment option that is beneficial for a wide range of individuals.

Eligibility criteria

Qualifiers

None

Disqualifiers

Cannot be pregnant at the time of treatment

Trial design

Treatments tested in this trial

  • Tirbanibulin ointment 1%
  • non-ablative fractional laser

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators